To confirm the sensitivity of SCLC to WEE1 inhibition, we measured the median half-maximal inhibitory concentration (IC50) of the WEE1 inhibitor AZD1775 in a panel of sixteen human and three murine SCLC cell lines (Figure 1A) after 5 days of treatment. This evidence concerns the gene WEE1 and small cell lung carcinoma.